Can't I stop taking Besudil once I take it? What issues do I need to pay special attention to when stopping medication?

Belumosudil (belumosudil) is a drug used to treat chronic graft-versus-host disease (cGVHD). Patients must strictly follow the doctor's instructions when using it. When discontinuing medication, patients should pay special attention to the following points to ensure safety and therapeutic efficacy.

1. Gradual reduction when discontinuing the drug: The discontinuation of Besudil is not sudden, but the dose needs to be gradually reduced according to the patient's condition. Physicians usually start considering discontinuing medications or adjusting dosages after a patient's condition has stabilized and treatment goals have been achieved. However, sudden discontinuation of medication may lead to recurrence or aggravation of the condition, so it must be done under the guidance of a professional doctor to avoid discontinuing medication on your own.

2. Possible symptoms: During the withdrawal process, patients may experience some discomfort or recurrence of symptoms. This includes recurrence of symptoms originally caused by cGVHD, such as skin problems, liver abnormalities, etc. Therefore, during the withdrawal process, patients need to closely observe changes in their condition and report any discomfort to their doctor in a timely manner. The doctor will adjust the treatment plan according to changes in the condition.

3. Monitoring and evaluation of gradual drug withdrawal: During the process of drug withdrawal, doctors will regularly evaluate the patient's response and conduct necessary examinations to ensure that the condition will not worsen after drug withdrawal. After stopping the medication, the doctor may recommend that the patient return for regular check-ups to monitor relevant indicators, such as liver function, kidney function, etc., to ensure that various body indicators are normal.

After stopping the medication, patients still need to maintain communication with their doctor, especially in the later stages of treatment. The doctor will decide whether to resume treatment or continue observation based on changes in condition and new examination results. Doctors may restart medication for patients who show signs of relapse. Therefore, patients should be patient and careful during the withdrawal process and follow all the doctor's recommendations.

Reference materials:https://www.rezuomib.com/